Related by context. All words. (Click for frequent words.) 71 Hemorrhagic Stroke caused 68 Cerebral Amyloid Angiopathy 64 AA amyloidosis 63 acute onset CINV 63 Hepatocellular Carcinoma HCC 62 delayed onset CINV 62 CYT# potent vascular disrupting 61 symptomatic BPH 61 kidney urologic 61 non alcoholic steatohepatitis 61 hepatitis C HCV 60 containing granisetron 60 Kepivance 60 atypical Hemolytic Uremic Syndrome 60 disease CDAD 60 postherpetic neuralgia PHN 60 AA Amyloidosis 60 phase IIb trial 60 Rilonacept 60 severe oral mucositis 60 pathologic myopia 60 post herpetic neuralgia PHN 60 FOLOTYN ® 60 Sezary syndrome 60 ELADUR ™ 59 Raptiva ® 59 treat dysmenorrhea 59 atherothrombotic events 59 gastrointestinal adverse reactions 59 ankylosing spondylitis AS 59 Silodosin 59 venous thromboembolic events 59 Cerebril TM 59 post surgical adhesions 59 Iluvien ® 59 organ transplant rejection 59 SNT MC# 59 rilonacept 59 invasive candidiasis 59 vaginally administered lidocaine 59 vaginal lidocaine product 59 PhotoPoint R 59 Prodarsan 58 Ozarelix 58 Torisel 58 oncolytic virus therapies 58 KETEK 58 gastro intestinal inflammation 58 relapsing remitting MS RRMS 58 arterial thrombosis 58 Epratuzumab 58 Hepatitis C HCV 58 receptor tyrosine kinase inhibitor 58 lucinactant 58 psoriatic arthritis PsA 58 herpes zoster shingles 58 cardio renal 58 Mucositis 58 oral mucositis OM 58 cytomegalovirus CMV retinitis 58 tramiprosate Alzhemed TM 58 AEG# 58 neovascular diseases 58 benign prostatic hyperplasia enlarged 58 Fibrillex TM 58 Phase III Pivotal 58 post menopausal osteoporosis 58 Cetrorelix 58 Loramyc R 58 Venous Thromboembolism VTE 58 budesonide foam 58 inflammatory autoimmune diseases 58 vaginal candidiasis 58 acyclovir Lauriad R 58 OMNARIS HFA 58 Retinitis Pigmentosa RP 58 Dacogen injection 58 Kit CD# positive 58 Advanced Renal Cell 58 delayed CINV 57 Staphylococcus aureus Polysaccharide Conjugate 57 Behcet uveitis 57 complement inhibitor eculizumab 57 recurrent glioma 57 arthritis PsA 57 Lupus nephritis 57 Pirfenidone 57 Ridaforolimus 57 brand ciclesonide HFA 57 multi kinase inhibitor 57 cat dander allergy 57 diarrhea predominant irritable 57 Phase III clinical trials 57 oral RSD# 57 POSIDUR TM ELADUR TM 57 Pivotal Trial 57 antiplatelet compound 57 methylnaltrexone bromide 57 YONDELIS 57 Vitrasert R 57 CDAD Clostridium difficile 57 prokinetic agent 57 rheumatoid arthritis psoriatic arthritis 57 MKC# MKC# PP 57 Dapagliflozin 57 idiopathic pulmonary fibrosis IPF 57 Ceflatonin R 57 structure infections ABSSSI 57 Malignant Melanoma 57 Degarelix 57 metastatic neuroendocrine tumors 57 Infusion reactions 57 aldehyde dehydrogenase ALDH2 deficiency 57 venous blood clots 57 phase IIb clinical 57 TRANSDUR ™ 57 GED aPC 57 Dupuytren Contracture 57 Amrubicin 57 chronic HCV infection 57 TELINTRA 57 Phase IIb Trial 57 ocular infections 57 Solazed TM 57 Azilect ® 57 Chronic lymphocytic leukemia 57 MT#/MEDI-# 57 hyperphenylalaninemia HPA due 57 candidates Azedra TM 57 StaphVAX R 57 dysplastic lesions 57 Raptiva R 57 OncoVex 57 gastrointestinal stromal tumors GIST 57 Aflibercept 57 diabetic retinopathy DR 57 toenail onychomycosis 57 PAOD 57 sapropterin dihydrochloride Tablets 57 biologic DMARD 57 Evoltra ® 57 sorafenib tablets 57 AFREZZA TM 56 lupus erythematosus 56 BCG refractory carcinoma 56 TYZEKA 56 miconazole Lauriad R 56 TTR amyloidosis 56 TORISEL 56 cobiprostone 56 DG# compounds targeting 56 thromboembolic disease 56 ZACTIMA TM ZD# 56 recurrent NSCLC 56 novel VDA molecule 56 CellCept mycophenolate mofetil 56 metastatic malignant 56 TRANSDUR ® 56 immunosuppressed patients 56 Pazopanib 56 SJIA 56 phase Ib clinical 56 thalidomide Thalomid 56 surgical adhesions 56 hypophosphatasia 56 Alzhemed TM 56 Diabetic Macular Edema 56 Fludara ® 56 cervical vulvar 56 cancer vaccine Norelin 56 Phase 1b clinical trials 56 gastrointestinal mucositis 56 QUADRAMET R 56 keloid scarring 56 glaucoma diabetic retinopathy 56 miconazole Lauriad ® 56 Actemra tocilizumab 56 Eculizumab 56 Mycograb 56 oral prodrug 56 BioNumerik 56 Vitrasert ® 56 Cimzia TM 56 CB2 selective receptor agonist 56 rALLy clinical trial 56 CD# monoclonal antibody 56 solid organ transplantation 56 REMOXY R 56 Pivotal Clinical Trial 56 panitumumab Vectibix 56 ulimorelin 56 dirucotide 56 colorectal bladder 56 cervical cancer precancerous 56 lexidronam injection 56 immuno inflammatory diseases 56 HuMax HepC 56 Tarceva TM 56 vitreoretinal disorders 56 Phase III Clinical Trials 56 investigational monoclonal antibody 56 Exherin TM 56 SUTENT ® 56 Archexin 56 Idiopathic Thrombocytopenic Purpura ITP 56 Pemphigus Vulgaris 56 cardiorenal disease 56 myocardial infarction ventricular fibrillation 56 DU #b 56 Enzastaurin 56 Apaziquone 56 tiapamil 56 leukemia ALL 56 cutaneous lupus 56 Nimotuzumab 56 receiving chemoradiation therapy 56 candidates bavituximab 56 metastatic colorectal 56 SUPPRELIN R LA 56 Cytomegalovirus CMV 56 polyneuropathy HIV DSP 56 efalizumab 56 Clevudine 56 ketolide antibiotic 56 occlusion CRVO 56 sumatriptan DosePro 56 Elagolix 56 Microplasmin 56 Systemic lupus erythematosus SLE 56 intraocular lenses IOLs phacoemulsification 56 forodesine 56 Teplizumab 56 dirucotide MBP# 56 Neulasta ® 56 NSAID induced 56 recurrent pulmonary embolism 55 Phase IIIb clinical 55 Shigamabs ® 55 Pulmonary Embolism PE 55 Phase III clinical 55 evaluating tivozanib 55 delivers fluocinolone acetonide FA 55 Neutrolin ® 55 postoperative atrial fibrillation 55 Phase III Clinical Trial 55 Bazedoxifene 55 familial amyloidotic polyneuropathy FAP 55 E2F Decoy 55 Brentuximab Vedotin SGN 55 Alzheimer disease cognitive impairment 55 Diabetic Macular Edema DME 55 HYVISC R 55 Rheumatoid Arthritis RA 55 lupus nephritis 55 vapreotide acetate 55 common neurovascular complication 55 Traficet EN 55 BENLYSTA TM 55 Nexavar sorafenib 55 RANK Ligand inhibitor 55 Golimumab 55 albiglutide 55 R Saizen R 55 virus HCV protease inhibitor 55 Icatibant 55 psoriasis rheumatoid arthritis 55 Phase 2b clinical 55 ALVESCO R 55 Amgen Neulasta R 55 MKC# MT 55 neovascular age 55 neurogenic orthostatic hypotension 55 autoimmune uveitis 55 dasatinib Sprycel ® 55 Candida infection 55 squalamine 55 rheumatoid arthritis juvenile idiopathic 55 Combination REOLYSIN R 55 hypervascular tumors 55 terlipressin 55 oral deforolimus 55 LHRH antagonists 55 Metastatic Prostate Cancer 55 R sorafenib tablets 55 MelaFind R 55 Chronic Myelogenous Leukemia CML 55 Diabetic Retinopathy 55 CTAP# Capsules 55 Onalta 55 PANVAC VF 55 erlotinib Tarceva ® 55 Idiopathic pulmonary fibrosis IPF 55 Aortic stenosis 55 post herpetic neuralgia 55 Phase Ib clinical 55 PEGINTRON TM 55 Glypromate 55 paroxysmal nocturnal hemoglobinuria 55 diabetic macular edema DME 55 candidemia 55 CollaRx R 55 cIAI 55 Phase Ib II 55 Skin Structure Infections 55 Certolizumab pegol 55 recurrent glioblastoma 55 idiopathic thrombocytopenic purpura ITP 55 SPRYCEL ® 55 GW# [003] 55 hereditary antithrombin deficiency 55 mertansine 55 Metastatic breast cancer 55 samarium Sm 55 constipation OIC 55 Vicinium TM 55 phenylketonuria PKU 55 HQK 55 benign prostatic hypertrophy BPH 55 myelodysplastic syndrome MDS 55 Unigene nasal calcitonin 55 leukotriene pathway 55 Velcade bortezomib 55 Roche PEGASYS R 55 ARIXTRA 55 Severe VOD 55 membranous nephritis 55 Kuvan R 55 docetaxel Taxotere ® 55 skeletal muscle weakness 55 HBeAg negative 55 phase IIa clinical 55 Achieves Primary Endpoint 55 targeted radiotherapeutic 55 Zemiva TM 55 Invasive fungal infections 55 ASPIRE HIGHER 55 Bronchiectasis 55 HGS# 55 Photodynamic Therapy PDT 55 personalized cellular immunotherapy 55 cutaneous T 55 Cutaneous T 55 prematurity ROP 55 Vidofludimus 55 Phase 2b Clinical Trial 55 hematologic disorders 55 actinic keratosis AK 55 INSPIRE Trial Phase III 55 LymphoStat B TM 55 Actimmune ® 55 * olmesartan medoxomil 55 cytomegalovirus infection 55 latent tuberculosis infection 55 Wet AMD 55 chronic opioid 55 LEUKINE 55 Acute Bacterial Sinusitis ABS 55 Phase 2a clinical 55 Hypertensive adverse reactions 55 Zolinza 55 CEQ# 55 pelvic malignancies 54 Safinamide 54 catheter occlusion 54 hepatitis C viral infection 54 postherpetic neuralgia 54 Crofelemer budesonide foam 54 inflammatory autoimmune 54 refractory gout 54 alpha interferons 54 First Patient Enrolled 54 symptomatic uterine fibroids 54 interstitial cystitis IC 54 IL# PE#QQR 54 Psoriatic arthritis 54 P#X# antagonist 54 acute radiation enteritis 54 Vicriviroc 54 RSD# oral 54 Troxatyl 54 LymphoStat B belimumab 54 oral Janus kinase 54 NeuroStar TMS Therapy 54 RELOVAIR ™ 54 deCODE Glaucoma TM 54 SinuNase TM 54 neuropathic pain spasticity 54 Tavocept 54 CMV disease 54 Idiopathic pulmonary fibrosis 54 NOXAFIL 54 TYKERB 54 diabetic retinopathy macular degeneration 54 secondary hyperparathyroidism 54 noninfectious uveitis 54 recurrent glioblastoma multiforme 54 Fx #A 54 systemic fungal infections 54 Contrast Induced Nephropathy 54 diseases bone metastasis 54 RhuDex ® 54 Omigard 54 pemphigus vulgaris 54 Phase IIb clinical trials 54 Prodarsan R 54 Lipsovir ® 54 retinal vein occlusion RVO 54 investigational therapies 54 pralatrexate injection folate analogue 54 dyskinesia PD LID 54 cryptococcosis 54 non metastatic osteosarcoma 54 adalimumab Humira 54 Aplidin R 54 severe hypersensitivity reactions 54 Diamyd ® 54 cathepsin K inhibitor 54 Chronic sinusitis 54 Budesonide foam crofelemer 54 Atopic dermatitis 54 Clolar ® 54 intravesical infusion therapy 54 multiple myeloma MM 54 ATTR PN 54 REMOXY ® 54 Friedreich Ataxia FRDA 54 bone metastasis 54 Glioblastoma Multiforme 54 PROGENSA R 54 immunocompetent patients 54 opioid bowel dysfunction 54 renovascular hypertension 54 Myocet 54 Combivir Kivexa 54 Initiates Enrollment 54 urinary catheter blockage 54 etanercept Enbrel 54 Bayer HealthCare Onyx Pharmaceuticals 54 Proxinium 54 recurrent metastatic ovarian cancer 54 Resurgex Plus R 54 overactive bladder syndrome 54 myelofibrosis polycythemia vera 54 GI motility disorders 54 Phase IIa trials 54 Loceryl ® 54 Acute myeloid leukemia AML 54 overactive bladder OAB 54 Catena ® 54 follicular lymphoma FL 54 initiate Phase IIb 54 Personalized Immunotherapy 54 heterozygous FH 54 ZACTIMA 54 Warfarin Coumadin 54 Lipsovir R 54 Annamycin 54 superficial bladder cancer 54 induced macular edema 54 COSIRA trial 54 Chronic Hepatitis B 54 Cleviprex TM clevidipine 54 Asthma COPD 54 Omigard TM 54 PrevOnco ™ 54 cell lymphoma CTCL 54 tuberous sclerosis TS 54 Nonalcoholic fatty liver 54 Adhesion Barrier 54 Phase IIIb study 54 oral JAK#/JAK# inhibitor 54 EchoCRT 54 Dasatinib 54 Cobalamin TM mediated 54 COMFORT II 54 HeFH 54 rheumatoid arthritis RA psoriatic 54 opioid induced constipation OIC 54 Noxafil 54 CHAMPION PCI 54 castrate resistant prostate cancer 54 vWD 54 IIa clinical trials 54 SUTENT 54 % uracil topical 54 deferiprone 54 Rheumatoid arthritis RA 54 invasive fungal infections 54 herpetic keratitis 54 biliary tract cancer 54 CCR9 antagonist 54 anterior uveitis 54 Phenoptin 54 GTC recombinant human 54 either acutely decompensated 54 Neovascular AMD 54 Gastric cancer 54 Sapacitabine 54 Ankylosing spondylitis 54 CRVO 54 LHON 54 Intravenous CP 54 Lupus Nephritis 54 Angioedema 54 Cimzia certolizumab pegol 54 cutaneous squamous cell carcinoma 54 opioid induced bowel dysfunction 54 Advanced Melanoma 54 plasma kallikrein inhibitor 54 BARACLUDE R 54 included exfoliative dermatitis 54 ATL/TV# 54 ZADAXIN ® 54 ALVESCO HFA 54 mTOR inhibitor 54 cytopenia 54 Thyroid Awareness Month 54 evaluating T DM1 54 paroxysmal nocturnal hemoglobinuria PNH 54 PRISTIQ 54 AzaSite TM 54 liver resection surgeries 54 PLX MS 54 transplantation HCT 54 optic neuropathy 54 Periodontal disease 54 metformin accumulation 54 histamine dihydrochloride 53 lomitapide 53 Esophagitis 53 Fodosine 53 erythema nodosum 53 R lenalidomide 53 Veronate 53 Ribavirin causes 53 antiangiogenesis therapies 53 nucleotide analog 53 visilizumab 53 SHPT 53 CAPACITY trials 53 colorectal cancer CRC 53 advanced metastatic renal 53 acute GVHD 53 relapsed multiple myeloma 53 paclitaxel poliglumex 53 post operative ileus 53 Myelofibrosis 53 posterior uveitis 53 proliferative diabetic retinopathy 53 5 HT3 antagonist 53 Nanobody 53 Acute myeloid leukemia 53 Teriflunomide 53 CBLC# 53 SPL# Gel vaginal microbicide 53 retinal vein occlusion 53 hypereosinophilic syndrome 53 Benign Prostatic Hyperplasia BPH 53 MYCAMINE 53 Childhood Blindness 53 relapsed refractory multiple myeloma 53 riociguat 53 Invasive Fungal Infections 53 vascular occlusive diseases 53 OvaRex ® MAb 53 Dupuytren Disease 53 CMV retinitis 53 Daclizumab 53 sunitinib malate 53 Cushing Syndrome 53 cerebral vasospasm 53 immunological diseases 53 CINV 53 Luveniq 53 ularitide 53 EXJADE 53 RAS MAPK pathway 53 constipation predominant irritable bowel 53 HuLuc# 53 retinal dystrophies 53 Onalta ™ 53 multicenter Phase 53 Quinamed 53 ischemic cardiac 53 Loramyc 53 placebo controlled clinical 53 clevudine 53 Levulan ® PDT 53 Serious Infections 53 randomized Phase IIb 53 ILUVIEN ® 53 Fibromyalgia Syndrome FMS 53 Oracea TM 53 Investigational Treatment 53 relapsed leukemia 53 Syndrome LEMS 53 velafermin 53 Systemic lupus erythematosus 53 delta gamma agonist 53 EVICEL 53 chemotherapy induced neutropenia 53 Non Alcoholic Steatohepatitis 53 basal cell carcinoma BCC 53 INS# [001] 53 Oncoscience AG 53 grade cervical intraepithelial 53 acetonide FA 53 macular edema 53 ROTARIX 53 Virulizin R 53 TMC# C# 53 XIAFLEX ® 53 TACI Ig 53 Alinia 53 Severe Sepsis 53 cardiovascular metabolic 53 ThermoDox R 53 FASLODEX 53 dermatological disorders 53 neurological manifestations 53 Pivotal Phase III 53 IMiDs ® compound 53 Leber Congenital Amaurosis LCA 53 Meets Primary Endpoint 53 Shigamabs R 53 immunocompromised patients 53 Relapsing remitting MS 53 HuMax TAC 53 proliferative retinopathy 53 Pivotal Study 53 cutaneous T cell 53 Multiple sclerosis MS 53 HuMax EGFr 53 Hsp# Inhibitor 53 ozarelix 53 Glufosfamide 53 endophthalmitis 53 Phase III trials 53 posaconazole 53 Phase IIa trial 53 relapsed MM 53 cervical carcinoma 53 hypersensitivity reaction 53 Factor VIIa 53 cystic fibrosis chronic pancreatitis 53 Empatic TM 53 Keppra R 53 HCD# [002] 53 OHR/AVR# 53 NOMID 53 Evoltra TM 53 Diabetic nephropathy 53 severe malignant osteopetrosis 53 diabetic nephropathy 53 angiotensin analog 53 Xanafide 53 BENICAR HCT 53 severe gastroparesis 53 rheumatoid arthritis osteoarthritis ankylosing 53 Irinotecan 53 systemic scleroderma 53 Viread tenofovir disoproxil fumarate 53 Nexavar ® 53 ENESTnd 53 debilitating complication 53 generation purine nucleoside 53 reslizumab 53 choroidal neovascularization 53 homozygous familial hypercholesterolemia 53 cancer related hypercalcemia 53 chronic thromboembolic pulmonary 53 ACE Inhibitors 53 Deferiprone 53 Acute lymphoblastic leukemia 53 ZYBRESTAT fosbretabulin 53 ductal carcinomas 53 Myelodysplastic Syndrome MDS 53 EVIZON TM 53 EDEMA3 53 INCB# [003] 53 NASH Huntington 53 tramiprosate 53 TAXUS Element Stent System 53 Anti VEGF 53 Lymphocytic 53 Critical Limb Ischemia CLI 53 HIV distal sensory 53 Prochymal TM 53 Onalta TM 53 Hypotension 53 acute GvHD 53 Myelodysplastic Syndrome 53 Sudhir Agrawal D.Phil 53 luliconazole 53 Oral NKTR 53 TG# [003] 53 Augment TM 53 AIR CF1 53 STRIDE PD 53 Aviptadil 53 Campath ® 53 Atypical Hemolytic Uremic Syndrome 53 Diabetic Ulcers 53 Tasimelteon 53 protein kinase inhibitors 53 recombinant biopharmaceutical 53 alvimopan 53 Ischemic 53 recurrent genital herpes 53 FDA APPROVES 53 TG MV 53 sodium thiosulfate STS 53 GATTEX TM 53 acute coronary syndromes ACS 53 mTOR kinase 53 Acute Myeloid Leukemia AML 53 Babesiosis 53 RNAi therapeutic targeting 53 Renal Cell Carcinoma RCC 53 S. aureus bloodstream infections 53 Zirgan 53 malignant neoplasms 53 smoldering myeloma 53 investigational humanized monoclonal antibody 53 Excellarate TM 53 lintuzumab SGN 53 oral methylnaltrexone 53 IMA# 53 herpes zoster virus 53 Recurrences 53 Lymphoseek ® 53 leukemia APL 53 Initiates Phase II 53 lumiliximab 53 jaundice yellowing 53 Celacade TM 53 NYHA Class II 53 hematologic diseases 53 chronic myeloid 53 Phase IIIb 53 chronically immunosuppressed solid 53 BRIM2 53 Optiquel ™ 53 renal failure interstitial lung 53 Hodgkin lymphoma HL 53 TNF Tumor Necrosis Factor 53 Phase 2a trial 53 grass pollen allergy 53 Restless Legs Syndrome RLS 53 investigational HCV polymerase 53 oral mucositis 53 bacterial conjunctivitis pink 53 purinergic receptors P#X# 53 thrombo embolic 52 vascular endothelial dysfunction 52 proliferator activated receptor 52 cirrhosis liver failure 52 Proxinium TM 52 FACTIVE ® 52 refractory chronic myeloid 52 LUMINATE 52 painful diabetic neuropathy 52 Methylnaltrexone 52 Uterine Cancer 52 systemic juvenile idiopathic 52 Respiratory Distress Syndrome 52 Aeolus Pharmaceuticals Announces 52 Ganite ® 52 symptomatic hyponatremia 52 assessing T DM1 52 clinical trials SGN 52 pancreas esophagus 52 JAK inhibitor 52 AQ4N 52 cervical anal 52 Atopic eczema 52 Hereditary angioedema HAE 52 Cardio Vascu Grow 52 HCV NS5B polymerase 52 RELISTOR ® 52 Romiplostim 52 necrotizing enterocolitis NEC 52 Acne vulgaris 52 afamelanotide 52 Systemic lupus 52 Tesetaxel 52 phase IIa 52 glucocorticoid induced osteoporosis 52 dasatinib Sprycel 52 metastatic renal cell carcinoma 52 HuMax Wnt 52 Apixaban 52 Relovair 52 CTO recanalization 52 Complicated Skin 52 Acute Radiation Syndrome ARS 52 SUCCEED trial 52 inhibit oxidative stress 52 carcinoma mCRC 52 bazedoxifene conjugated estrogens 52 PEG INTRON R 52 antibody MAb 52 bevacizumab Avastin ® 52 candidate CRLX# 52 phase IIb study 52 Tanespimycin 52 transthyretin TTR mediated amyloidosis 52 oral calcitonin 52 mycosis fungoides 52 hypoxia activated prodrug 52 lymphoma CTCL 52 Pivotal Phase 52 Peripheral Artery Disease 52 chronic renal disease 52 CCR5 antagonist 52 patients undergoing percutaneous 52 CIMZIA ™ 52 SYMMETRY SM trial 52 GERD migraine headaches 52 pseudobulbar affect PBA 52 vaccines oncolytic virus 52 PEGylated interferon beta 1a 52 delivery polymer matrix 52 AzaSite Xtra 52 Medidur ™ FA 52 Cotara ® 52 AZX# 52 Zenvia ™ 52 Phase 2b trial 52 systemic Phase 1b 52 acute peripheral arterial 52 Retinopathy 52 TNFerade ™ 52 Deforolimus 52 ischemic complications 52 ospemifene 52 atherosclerosis hypertension 52 LEVAQUIN 52 juvenile idiopathic arthritis 52 faropenem medoxomil 52 eosinophilic asthma 52 Onychomycosis 52 ecallantide 52 PORxin TM platforms 52 multicenter Phase III 52 dermatology therapies 52 ABRAXANE TM 52 Genasense ® 52 ixabepilone 52 Age Related Macular 52 syndrome gastroesophageal reflux 52 Pegloticase 52 ocrelizumab 52 Aurexis 52 tafluprost 52 Phase Ib 52 Chronic Sinusitis 52 ORENCIA R 52 Pulmonary arterial hypertension 52 TNFerade TM 52 hypertrichosis occurred 52 Darapladib 52 Talabostat 52 Hormone Refractory Prostate Cancer 52 Nephrogenic Systemic Fibrosis NSF 52 oral ridaforolimus 52 PREOS R 52 Indaflex TM 52 PGL# 52 ChromoCure develops 52 osteoarthritis rheumatoid arthritis 52 ETEC vaccine 52 acute humoral rejection 52 Pulmonary Arterial Hypertension PAH 52 chronic eosinophilic leukemia 52 EQUIP OB 52 Curaxin CBLC# 52 Insegia 52 Arno Therapeutics 52 Uterine Fibroid Embolization 52 systemic autoimmune 52 BENLYSTA ® 52 dilated cardiomyopathy DCM 52 evaluating REVLIMID 52 Xyfid TM 52 ovarian breast 52 Cannabinor 52 PEG INTRON 52 Mg Usa 52 Catheter Associated 52 Stomach cancer 52 stage IIIB 52 respiratory gastrointestinal 52 BioSTAR R 52 Critical Limb Ischemia 52 elotuzumab 52 Allovectin 7 R 52 oral FTY# 52 systemic lupus erythematosus SLE 52 Onco TCS 52 gastrointestinal GI motility disorders 52 LibiGel ® 52 Rhucin R 52 Provectus Pharmaceuticals specializes 52 Ulcerative colitis 52 Xyfid 52 FUSILEV ® 52 Seborrheic dermatitis 52 Toxicities 52 Intravitreal injections 52 gastrointestinal stromal tumors GISTs 52 invasive aspergillosis 52 chronic anal fissures 52 Abbokinase 52 Panzem R 52 sunitinib Sutent ® 52 Vectibix panitumumab 52 Cellegesic 52 Ventavis 52 Therapeutic Vaccine 52 systems viscoelastics 52 pertuzumab 52 Trofex TM 52 phase III isavuconazole 52 Alemtuzumab 52 venous stasis ulcers 52 Phase 1b trial 52 phase Ib 52 Hypoactive Sexual Desire Disorder 52 Erythropoietic therapies may 52 postmenopausal osteoporosis 52 PNP inhibitor 52 ulcerative mucositis 52 Fenretinide 52 blinded randomized placebo controlled 52 Leber Hereditary Optic Neuropathy 52 Soliris eculizumab 52 Li Fraumeni Syndrome 52 HDAC Inhibitor 52 sapacitabine CYC# 52 Tindamax R 52 Venous Thromboembolism 52 atherothrombosis 52 malignant mesothelioma Alfacell 52 lead Aganocide compound 52 Allovectin 7 52 Cytogen marketed 52 pulmonary hypertension PH 52 isavuconazole 52 Orphan Drug Status 52 Chemotherapy induced 52 Ophena 52 generalized seizures 52 targeted radiotherapeutics 52 AAT Deficiency 52 CDP# 52 Vaprisol 52 nonmelanoma skin cancers 52 Colorectal cancers 52 Xcytrin R 52 congenital ichthyosis 52 phase IIb III 52 antifungal therapy 52 overactive bladder AA# 52 postherpetic neuralgia PHN painful 52 pancytopenia 52 nasopharyngeal carcinoma 52 Aplidin 52 abdominal abscesses 52 chorea associated 52 BRIM3 52 ARCALYST ® 52 Central Retinal Vein 52 Phase 2b clinical trials 52 docetaxel Taxotere R 52 Telavancin 52 candidate Zenvia 52 debilitating autoimmune 52 AGILECT R 52 Drug Eluting Stent System 52 Recombinant interferon alpha 52 aHUS 52 Tesmilifene 52 pediatric acute lymphoblastic 52 azathioprine monotherapy 52 nasal decolonization 52 ARCOXIA 52 Menopausal hormone therapy 52 progressive neurodegenerative disorder 52 pulmonary fungal infections 52 dentinal hypersensitivity 52 MALT lymphoma 52 Juvenile Idiopathic Arthritis 52 chronic myocardial ischemia 52 BUPHENYL 52 Peripheral arterial disease 52 indolent NHL 52 prophylactic therapy 52 elevated intraocular pressure